131
Participants
Start Date
February 1, 2021
Primary Completion Date
January 28, 2023
Study Completion Date
January 28, 2023
risdiplam
Risdiplam will be administered orally at a single dose of 5 mg in different formulations. Dispersible tablet formulations (F21/F22) will be administered as swallowed tablet or as tablet dispersed in water. The powder for constitution to an oral solution will be administered as an oral solution constituted with purified water.
omeprazole
Omeprazole will be administered orally as a capsule at a dose of 40 mg per day
Daytona Beach Clinical Rsch Unit, Daytona Beach
Covance Clinical Research Unit, Inc, Madison
QPS- Springfield, Springfield
Dallas Clinical Research Unit, Dallas
Hoffmann-La Roche
INDUSTRY